Substance Use & Misuse最新文献

{"title":"Peer E-Cigarette and Cannabis Use and Adolescent Anxiety: Findings from a Mixed-Methods Study.","authors":"Ryan Lee, Shirin Emma Herzig, Carla Michelle Ramirez, Daniel Soto, Jennifer B Unger","doi":"10.1080/10826084.2024.2446738","DOIUrl":"https://doi.org/10.1080/10826084.2024.2446738","url":null,"abstract":"<p><strong>Objective: </strong>Adolescents are typically motivated to conform to peer influence, including substance use behaviors, and it is likely that adolescents who deviate from their peers' substance use behaviors might experience stress and anxiety.</p><p><strong>Method: </strong>A mixed-methods approach was utilized to examine the relationship between peer e-cigarette and cannabis use and symptoms of generalized anxiety among a diverse sample of 12^th grade students in Los Angeles County, California, USA (<i>N</i> = 1,867, <i>M</i>_age = 17.04, SD = 0.43). Multivariable logistic regression models examined the associations between peer substance (e-cigarette and cannabis) use and anxiety. The interactions of prior e-cigarette and cannabis use on these relationships were also tested. Focus group data (<i>n</i> = 27) were analyzed to identify themes that could further inform the quantitative associations.</p><p><strong>Results: </strong>Peer cannabis use was associated with increased odds of moderate - severe generalized anxiety (OR = 1.47, <i>p</i> = 0.02), but peer e-cigarette use was not (OR = 1.20, <i>p</i> = 0.28). These relationships were moderated by prior history of e-cigarette and cannabis use (OR = 0.44, <i>p</i> = 0.02; OR = 0.31, <i>p</i> = 0.001, respectively). Focus group findings highlighted exposure to friends and peers using substances and having mixed feelings surrounding peer use, including feelings of anxiety and discomfort with being around friends using substances or deviating from their friends' substance use behaviors.</p><p><strong>Conclusion: </strong>These findings highlight the difficulties for teens navigating peer relationships and peer influence as their friends decide to participate in risky behaviors. Better health programs and interventions addressing peer influence, advocacy, and respecting one's decision to not use substances is needed.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"1-11"},"PeriodicalIF":1.8,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Examining the Relationship between Culture and Perceived Societal Substance Use Stigma in a Michigan-Based Mental Health & Addiction Focused Community.","authors":"Mayson K Whipple, Hannah Boyke, Robert C Ferrier, Pilar S Horner","doi":"10.1080/10826084.2024.2422948","DOIUrl":"10.1080/10826084.2024.2422948","url":null,"abstract":"<p><p><i>Introduction:</i> Substance use disorder (SUD) stigma undermines the implementation of effective harm reduction and treatment strategies in the U.S. and can impede individuals from seeking treatment. One research question guided this study: How do personal beliefs regarding SUD, familiarity with SUDs, and culture (religion, political ideology, and urbanicity), shape perceived societal SUD stigma? <i>Methods:</i> An online survey was sent to affiliates of a Michigan-based organization, Families Against Narcotics and administrators of Michigan Prepaid Inpatient Health Plan regional entities (<i>N</i> = 1,559). <i>Results:</i> On average respondents viewed society as moderately stigmatizing. The beliefs that drug users can stop whenever they want and that drug users have weak character were significantly associated with greater perceived levels of societal SUD stigma. The effects of religion on perceived stigma may be affected by beliefs of the immorality of drug use, while the effects of political ideology on perceived stigma may differ based on beliefs of the controllability of drug use. The effect of urbanicity may rely on perceived accessibility of treatment. <i>Conclusion:</i> Our findings reflect the intersection of personal beliefs and cultural contexts as they shape perceived societal SUD stigmatization.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"176-187"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142584381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Need Frustration and E-Cigarette Use and Dependence Among College Students: The Mediating Role of Ruminative Thinking.","authors":"Folly Folivi, Anna M Petrey, Adrian J Bravo, Laura J Holt, Alison Looby","doi":"10.1080/10826084.2024.2422951","DOIUrl":"10.1080/10826084.2024.2422951","url":null,"abstract":"<p><p><i>Background</i>: The prevalence and dependence of e-cigarettes have increased among young adult college students in recent years. Though several independent risk factors for e-cigarette use and dependence have been identified, research employing theory-informed models to predict e-cigarette use and dependence is limited. <i>Objectives</i>: Using Self Determination Theory (SDT), e-cigarette use and dependence may be understood as stemming from need frustration that impairs autonomy, competence, and relatedness, which increases vulnerability for negative health outcomes, including e-cigarette use. Further, need frustration may relate to more e-cigarette use and dependence via higher ruminative thinking, which is known to relate to both need frustration and tobacco use. <i>Method</i>: This study tested this path model (i.e., SDT need frustration components [autonomy, relatedness, competency]→rumination facets [problem-focused thoughts, counterfactual thinking, repetitive thinking, anticipatory thoughts]→e-cigarette use frequency and dependence outcomes) among 1001 college students (75.3% female; 60.4% White, non-Hispanic; 52% first-year students) who endorsed past-month e-cigarette use. <i>Results</i>: Within our path model, we found significant indirect effects via problem-focused thoughts on e-cigarette use frequency and e-cigarette dependence. Specifically, higher scores on SDT autonomy, competence, and relatedness frustration were associated with greater problem-focused thoughts, which was associated with higher e-cigarette use frequency and e-cigarette dependence scores. <i>Conclusions/Importance</i>: Results highlight the importance of distinguishing between the unique facets of rumination in understanding relations with e-cigarette use. Further intervention research targeting need frustration and ruminative thinking (particularly problem-focused thoughts) among college student e-cigarette-dependent users is needed.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"202-210"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cognitive Enhancers Consumption: Prevalence, Knowledge, and Determinants of Use Among Medical Students in Egypt, Sudan, and Jordan.","authors":"Yousef Hawas, Motasem Ayoub, Esraa Esmail, Mona Mahmoud Elsakka, Marina Antonios, Andrew Azeez, Shereen Gahlan, Fatima Hamadein, Yasmeen Alabdallat, Mirna Maged Armanyos, Danya Mustafa Ibrahim, Hussam Adam Ishag, Mohamed Mahmoud Qassem, Areen Anwer Melhem, Mai Alaaeldin Elsebaie, Farah Riyad Mohamed, Leen Mohammad Alhanandeh, Hadeel Mohammad Abusaifan","doi":"10.1080/10826084.2024.2434001","DOIUrl":"10.1080/10826084.2024.2434001","url":null,"abstract":"<p><strong>Background: </strong>Cognitive Enhancers (CE) are central nervous system stimulant substances known to improve cognitive functions. Due to high-perceived stress and academic pressure, CEs are becoming increasingly popular among medical students. As a result, they are more likely to misuse these substances.</p><p><strong>Objectives: </strong>This study aims to estimate the prevalence of CE consumption, compare the prevalence between countries and genders, and identify characteristics associated with CE consumption among students at medical schools in Egypt, Sudan, and Jordan.</p><p><strong>Method: </strong>A population-based survey study was conducted among medical students from Egypt, Sudan, and Jordan. An online self-reported questionnaire was used to collect data. Frequencies and percentages were calculated to represent participant distribution across categories. Chi-square was used for categorical variables comparisons. All tests were two-tailed, considering <i>p</i> < 0.05 statistically significant. Demographic characteristics, reasons for use, types of CE used, and side effects were compared by country and gender.</p><p><strong>Results: </strong>A total sample of 1399 participated in the questionnaire, most of whom were females 824 (58.9%). Overall, 1236 (88.3%) were CE consumers, and 163 (11.7%) were non-consumers. Of the respondents who used CE, 814 (58.2%) reported using them daily. There was a statistically significant difference between the consumption of CE and the source of acquisition, nationality, and residence status regarding gender.</p><p><strong>Conclusions: </strong>Our findings suggest that CE use is increasing among medical students in Egypt, Sudan, and Jordan. Efficient support, stress management programs, and awareness symposia may help reduce the misuse of these substances. Future longitudinal studies are still required.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"436-441"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142751728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"\"Drug Use with Racism…The Reason I Wanted to Do This Study\": Perceptions of Race and Racism's Impact on Drug Use among Black Americans Using Opioids.","authors":"Natalie Malone, Gabriella R Pitcher, Destin L Mizelle, Paris Wheeler, Brittany Miller-Roenigk, Kendall A McCleod, Mekaila Keeling, Tristan Ntego, Candice N Hargons, Danelle Stevens-Watkins","doi":"10.1080/10826084.2024.2423371","DOIUrl":"10.1080/10826084.2024.2423371","url":null,"abstract":"<p><p><b>Background</b>: Several studies link racism with drug use disparities among systemically marginalized populations. However, few invite Black Americans to discuss how they perceive racism's impact on their drug use. <b>Objectives</b>: To examine qualitative accounts from N=40 Black adults reporting non-medical prescription opioid use on their experiences of racism and drug use. <b>Results</b>: A deductive structural tabular thematic analysis informed by Jones's (2000) levels of racism resulted in two themes: (a) Experiences of Racism (subthemes: Denying Experiences of Racism and Endorsing Experiences of Racism) and (b) Race, Racism, and Drug Use (subthemes: Rejecting Race and Racism's Impact on Drugs and Rejecting Race and Racism's Impact on Drugs). <b>Conclusions</b>: Participants provided examples of internalized, personally mediated, and institutionalized racism associated with their drug use. Implications for policy, practice, and research are discussed. Specifically, implications detail how to center Black Americans and demonstrate anti-racism when developing treatment strategies and drug policies.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"265-275"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013.","authors":"Deborah S Hasin, Zachary L Mannes, Ofir Livne, David S Fink, Silvia S Martins, Malki Stohl, Mark Olfson, Magdalena Cerdá, Katherine M Keyes, Salomeh Keyhani, Caroline G Wisell, Julia M Bujno, Andrew Saxon","doi":"10.1080/10826084.2024.2423374","DOIUrl":"10.1080/10826084.2024.2423374","url":null,"abstract":"<p><strong>Background: </strong>Rates of cannabis use disorder (CUD) have increased disproportionately among Veterans Administration (VA) patients with psychiatric disorders compared to patients with no disorder. However, VA patient samples are not representative of all U.S. adults, so results on disproportionate increases in CUD prevalence could have been biased. To address this concern, we investigated whether disproportionate increases in the prevalence of cannabis outcomes among those with psychiatric disorders would replicate in nationally representative samples of U.S. adults.</p><p><strong>Methods: </strong>Data came from two national surveys conducted in 2001-2002 (<i>n</i> = 43,093) and 2012-2013 (<i>n</i> = 36,309). Outcomes were any past-year non-medical cannabis use, frequent non-medical use (≥3 times weekly), and DSM-IV CUD. Psychiatric disorders included mood, anxiety and antisocial personality disorders. Logistic regression was used to generate predicted prevalences of the outcomes, prevalence differences calculated and additive interactions compared differences between those with and without psychiatric disorders.</p><p><strong>Results: </strong>Cannabis outcomes increased more among those with psychiatric disorders. The difference in prevalence differences included any past-year non-medical cannabis use, 2.45% (95%CI = 1.29-3.62); frequent non-medical cannabis use, 1.58% (95%CI = 0.83-2.33); CUD, 1.40% (95%CI = 0.58-2.21). For most specific disorders, prevalences increased more among those with the disorder.</p><p><strong>Conclusions: </strong>In the U.S. general population, rates of cannabis use and CUD increased more among adults with psychiatric disorders than other adults, similar to findings from VA patient samples. Results suggest that although VA patients are not representative of all U.S. adults, findings from this important patient group can be informative. Greater clinical and policy attention to CUD is warranted for adults with psychiatric disorders.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"285-292"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11710973/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Including Families in a Response to the Unregulated Toxic Drug Crisis: A Call to Action.","authors":"Holly Mathias, Sarah Auger, Petra Schulz, Elaine Hyshka","doi":"10.1080/10826084.2024.2431042","DOIUrl":"10.1080/10826084.2024.2431042","url":null,"abstract":"<p><p>The unregulated toxic drug crisis continues to be an urgent health issue in North America. Many families of people who use drugs have been significantly impacted by this issue. In addition to the thousands of North Americans who have been bereaved by drug mortality, many families are providing unpaid care to bridge gaps in services while navigating the grief and stress associated with caring for a loved one amidst a heavily politicized and rapidly changing context. Despite the impact on families, few interventions are in place to lessen the burden of the crisis. This commentary presents a call to action to include families of people who use drugs in a public health response to the toxic drug crisis. We emphasize the need for (1) the consideration and involvement of families in all aspects of policy and program decision making, (2) the recognition of families of people who use drugs within national caregiving and bereavement strategies; (3) increased supports and services for families; and (4) additional research and public health monitoring on the impact of the toxic drug crisis on families.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"452-456"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Medications for Opioid Use Disorder in People Who Inject Substances: Reflection on the Potential Place of Morphine Sulfate as Substitution Treatment? Results of COSINUS Cohort Study.","authors":"Laurence Lalanne, Julio Ricardo Davalos, Martin Audran, Naomi Hamelin, Carole Chauvin, Laelia Briand-Madrid, Charlotte Kervran, Sébastien Kirchherr, Marc Auriacombe, Perrine Roux, Marie Jauffret-Roustide","doi":"10.1080/10826084.2024.2434005","DOIUrl":"10.1080/10826084.2024.2434005","url":null,"abstract":"<p><strong>Background: </strong>Opioid Use Disorder (OUD) often provokes dramatic consequences in terms of increased morbi-mortality. Two medications have mainly been worldwide used for OUD (MOUD), buprenorphine and methadone. Recently, however, some reports have highlighted the use of Morphine Sulfate (MS) mainly obtained without a prescription but used as MOUD by opioid users and especially People Who Inject Substances (PWIS). We propose to characterize the prevalence and distribution of MOUD and MS use in PWIS.</p><p><strong>Methods: </strong>This study examines the use of MOUD and MS amongst French PWIS recruited in harm reduction facilities and drug consumption rooms in the context of the COSINUS (Cohort to assess structural and individual factors in drug use) study.</p><p><strong>Results: </strong>MOUD are prescribed, respectively, to one-third and one-fifth of PWIS, whereas a half of them declared MS consumption without prescription. MS users live with higher precariousness and are younger than non-users. MS is associated with salt cocaine and heroin use. It is often consumed with methadone and more rarely with buprenorphine and we hypothesized that this is probably linked to buprenorphine's pharmacological antagonism.</p><p><strong>Discussion: </strong>Our results show the high prevalence of MS consumption and highlight the importance of considering the highly restricted possibility of prescribing MS as MOUD. Its association with methadone raises the question of their synergistic action on craving and mental disorders. The profiles of opioid users who could benefit from MS with or without methadone must be examined to improve their care but with the utmost caution, given the risk of overdose.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"393-402"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142802318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Use of Diverted Buprenorphine by Individuals Initiating Telehealth Opioid Use Disorder Treatment.","authors":"Scott G Weiner, Emily N Miller, Brian Clear","doi":"10.1080/10826084.2024.2434006","DOIUrl":"10.1080/10826084.2024.2434006","url":null,"abstract":"<p><p><i>Background:</i> Telehealth-only provision of buprenorphine for opioid use disorder was made possible during the COVID-19 pandemic, but policymakers are considering ending this practice. A primary concern is potential diversion of buprenorphine, although it is unknown how many patients enter telehealth-only treatment already using diverted buprenorphine. <i>Methods:</i> We performed a retrospective chart review of 500 consecutive newly enrolled patients in our large telehealth-only program in January 2023. We recorded if the patient was already taking buprenorphine at the time of the intake visit and if the buprenorphine was from a diverted source. <i>Results:</i> Five hundred patients enrolled from January 3-20, 2023. Patients were 61.0% male; mean age was 40.3 (standard deviation 10.3) years. Buprenorphine use at the time of enrollment was reported by 46.4% (<i>n</i> = 232) of patients, and 18.4% (<i>n</i> = 92) reported using diverted buprenorphine. <i>Conclusions/Importance:</i> Over one in six patients initiating care with our telehealth-only practice reported taking diverted buprenorphine. These findings indicate that the telehealth care setting possibly decreases diversion of buprenorphine when patients use this modality to obtain legitimate treatment.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"442-445"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recovery Capital and Subsequent Overdose Risk and Addiction Treatment Engagement Among Emergency Department Patients at High Risk of Opioid Overdose.","authors":"Laura C Chambers, Ralph A Welwean, Daniel K Cho, Kirsten J Langdon, Yu Li, Benjamin D Hallowell, Mackenzie M Daly, Brandon D L Marshall, Francesca L Beaudoin","doi":"10.1080/10826084.2024.2434003","DOIUrl":"10.1080/10826084.2024.2434003","url":null,"abstract":"<p><strong>Background: </strong>Emergency department (ED) visits are an opportunity to provide prevention services to people at high risk of overdose. Considering patients' resources to initiate and sustain recovery (\"recovery capital\") may be useful for tailoring ED services, although its relevance in this population is unknown.</p><p><strong>Methods: </strong>This secondary analysis used data from ED patients at high risk of opioid overdose enrolled in a randomized controlled trial in Rhode Island (2018-2021). We assessed baseline recovery capital using the Brief Assessment of Recovery Capital (BARC-10), dichotomized as a total score <47 versus ≥47. Post-discharge addiction treatment engagement within 30 days and non-fatal opioid overdose and fatal overdose within 18 months were assessed using statewide administrative data. We used modified Poisson regression and Cox proportional hazards models to estimate the association between recovery capital and (1) treatment engagement and (2) overdose risk, respectively, adjusting for potential confounders.</p><p><strong>Results: </strong>Among 543 participants, 32.2% had a baseline BARC-10 total score of ≥47, 32.6% engaged in treatment within 30 days, and 25.6% had a non-fatal opioid overdose and 4.2% had a fatal overdose within 18 months. BARC-10 total score was not associated with treatment engagement within 30 days (adjusted relative risk = 0.79, 95% confidence interval [CI] = 0.60-1.05) or non-fatal opioid overdose (adjusted hazard ratio [aHR] = 0.83, 95%CI = 0.57-1.20) or fatal overdose (aHR = 0.45, 95%CI = 0.14-1.40) within 18 months.</p><p><strong>Conclusion: </strong>The majority of ED patients at high risk of opioid overdose had a BARC-10 total score of <47, suggesting low recovery capital. BARC-10 total score was not associated with post-discharge treatment engagement or overdose risk.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"381-392"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11769765/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}